Jimenez Santos Jose Ignacio 4

What Happened

• Jose Ignacio Jimenez Santos, a director of ProKidney Corp. (PROK), was granted 135,000 derivative awards on 2026-05-28. The filing reports an acquisition of 135,000 shares at $0.00 (transaction code A — award/grant). This was a compensation grant (not an open‑market purchase or sale).

Key Details

• Transaction date: 2026-05-28 (filed 2026-05-29)
• Instrument: Derivative award (options/awards) for 135,000 shares; reported price/exercise = $0.00
• Vesting: Vests in full on the earlier of the one‑year anniversary of the grant or the Company’s next annual general shareholder meeting (per footnote)
• Grant source: Issued under the issuer’s non‑employee director compensation policy (per footnote)
• Shares owned after transaction: Not disclosed in the provided Form 4 summary
• Timeliness: Filing appears timely (reported the next day)

Context

• This is a routine director compensation award rather than an open‑market trade; such grants are commonly used to compensate non‑executive board members. As a derivative award, the filing does not by itself indicate a buy/sell sentiment — it documents a grant of equity‑linked compensation with the vesting schedule noted above.